Why it fits
New confusion/hallucinations/paranoia after medication changes, polypharmacy
New confusion/hallucinations/paranoia after medication changes, polypharmacy
Anticholinergic delirium, steroid mania/psychosis, opioid toxicity, falls, urinary retention.
Inattention and fluctuating awareness are the key separators; psychotic content is often fragmentary.
Separates the Older-Adult First-Presentation Psychosis Traps group. It is not specific to Medication toxicity.
Applies to the Older-Adult First-Presentation Psychosis Traps group — not specific to Medication toxicity
Rows marked “Whole group”: Applies to the Older-Adult First-Presentation Psychosis Traps group — not specific to Medication toxicity
New confusion/hallucinations/paranoia after medication changes, polypharmacy
Anticholinergic delirium, steroid mania/psychosis, opioid toxicity, falls, urinary retention.
Applies to the Older-Adult First-Presentation Psychosis Traps group.
Inattention and fluctuating awareness are the key separators; psychotic content is often fragmentary.
Applies to the Older-Adult First-Presentation Psychosis Traps group.
Acute change in an older person is delirium until proved otherwise Lewy body disease is a classic trap in late-life psychiatry The medication list is one of the highest-yield late-life investigations Even modest recent changes or cumulative burden can precipitate delirium
Applies to the Older-Adult First-Presentation Psychosis Traps group.
None listed
Applies to the Older-Adult First-Presentation Psychosis Traps group.
None listed
Clinical reference — not validated decision support. Review before use.